MYSZ:NASDAQMy Size, Inc. Analysis
Data as of 2026-07-16 - not real-time
$0.44
Latest Price
8/10Risk
Risk Level: High
Executive Summary
My Size, Inc. is trading at $0.44, which sits below its 20‑day (≈$0.46), 50‑day (≈$0.50) and 200‑day (≈$0.76) moving averages, signaling a bearish price trend. The RSI of 43 and a modestly bullish MACD histogram suggest limited upside momentum, while volume is on a downtrend and 30‑day volatility is sky‑high at over 80%, underscoring a fragile market environment.
On the fundamentals side, the company posted $10.3 M in revenue with a strong 62% YoY growth, yet margins are deeply negative (operating margin –58%, profit margin –61%) and cash flow is sharply negative, draining cash reserves. The balance sheet shows a debt‑to‑equity ratio above 30, a low price‑to‑book of 0.54 and a market cap of just $2.1 M, making the stock appear cheap on a book basis but highly leveraged and cash‑starved. The extreme‑greed sentiment (93.5 on the Fear & Greed Index) may be inflating price expectations despite the underlying financial weakness.
On the fundamentals side, the company posted $10.3 M in revenue with a strong 62% YoY growth, yet margins are deeply negative (operating margin –58%, profit margin –61%) and cash flow is sharply negative, draining cash reserves. The balance sheet shows a debt‑to‑equity ratio above 30, a low price‑to‑book of 0.54 and a market cap of just $2.1 M, making the stock appear cheap on a book basis but highly leveraged and cash‑starved. The extreme‑greed sentiment (93.5 on the Fear & Greed Index) may be inflating price expectations despite the underlying financial weakness.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below key moving averages
- Decreasing volume and extreme volatility
- Negative operating cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth potential
- Persistent operating losses and cash burn
- Low market cap limiting institutional support
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Undervalued book value
- High debt burden and leverage
- Uncertain path to profitability
Key Metrics & Analysis
Financial Health
Revenue Growth61.90%
Profit Margin-60.99%
P/E Ratio-0.2
ROE-125.59%
ROA-43.09%
Debt/Equity32.35
P/B Ratio0.5
Op. Cash Flow$-5943000
Free Cash Flow$-3498500
Industry P/E34.0
Technical Analysis
TrendBearish
RSI43.4
Support$0.40
Resistance$0.50
MA 20$0.46
MA 50$0.50
MA 200$0.76
MACDBullish
VolumeDecreasing
Fear & Greed Index93.45
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.28
Volatility83.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.